EPISODE · Aug 15, 2024 · 11 MIN
Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD
from Let’s Talk Ophthalmology: an Evolve Medical Education Podcast · host Evolve Medical Education, LLC
David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
What this episode covers
David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
NOW PLAYING
Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m